| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |